Stock Market Reviews

TEVA (Teva Pharmaceutical Industries Limited) News

Get the latest news, insights, and market updates on TEVA (Teva Pharmaceutical Industries Limited). Explore the news page 7 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• We Like The Quality Of Teva Pharmaceutical Industries' (NYSE:TEVA) Earnings
  Teva Pharmaceutical Industries Limited ( NYSE:TEVA ) announced a healthy earnings result recently, and the market...
  Nov 12, 2025 - $TEVA
• Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?
  Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
  Nov 10, 2025 - $TEVA
• How Recent Developments Are Rewriting the Story for Teva Pharmaceutical Industries
  Teva Pharmaceutical Industries has seen its fair value price target rise from $24.44 to $27.45, reflecting renewed optimism among analysts after the latest quarterly updates. This upward shift comes as revenue growth projections have improved from 2.43% to 2.77%, supported by positive trends in drug pricing and sales volumes. Stay tuned to learn how you can stay ahead of future developments in Teva’s evolving investment story. Analyst Price Targets don't always capture the full story. Head...
  Nov 9, 2025 - $TEVA
• Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?
  Here is how Teva Pharmaceutical Industries Ltd. (TEVA) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.
  Nov 7, 2025 - $TEVA
• AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living
  In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their lives impacted by tardive dyskinesia (TD) while taking AUSTEDO or AUSTEDO XRMost (85%) participants taking AUSTEDO or AUSTEDO XR in conjunction with their mental health medications reported that their mental health condition remained stable or improved Teva is committed to truly understanding and empowering individuals living with TD to help improve their TD and regain th
  Nov 7, 2025 - $TEVA
• S&P 500 Futures Dip as Rate and Debt Worries Mount
  The Morning Bull - US Market Morning Update Thursday, Nov, 6 2025 US stock futures are pointing lower ahead of the open, as investors react to news that US household debt has climbed to a fresh all-time high and the 10-year Treasury yield has pushed to its highest level in a month. Signs of persistent borrowing and rising rates are stirring fresh concern about consumer resilience and the cost of credit, which is putting pressure on the broader equity market as investors weigh the trajectory...
  Nov 6, 2025 - $TEVA
• Teva (TEVA) Hits Multi-Year High as Q3 Strengthens FY25 Profitability Expectations
  We recently published 10 Big Names Leading Wall Street Gains. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is one of the best-performing stocks on Wednesday. Teva rallied to a new multi-year high on Wednesday after a stellar performance in the third quarter solidified expectations for a profitable full-year 2025. In intra-day trading, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) […]
  Nov 6, 2025 - $TEVA
• TEVA Q3 Earnings & Revenues Beat, Austedo Sales View Raised, Stock Up
  Teva stock jumps after third-quarter earnings and revenues top estimates, driven by robust Austedo sales as well as U.S. generics growth.
  Nov 6, 2025 - $TEVA
• Teva Canada Welcomes RAMQ Reimbursement Update Supporting Access to ADHD Treatments
  Teva Canada welcomes the recent announcement from Québec's Ministry of Health regarding changes to the reimbursement framework for extended-release methylphenidate products. Effective December 11, 2025, the Régie de l'assurance maladie du Québec (RAMQ) will apply the "lowest price" method to the molecule category "methylphenidate (hydrochloride) Co. L.A (12 h)."
  Nov 6, 2025 - $TEVA
• Here's What Key Metrics Tell Us About Teva Pharmaceutical Industries (TEVA) Q3 Earnings
  Although the revenue and EPS for Teva Pharmaceutical Industries (TEVA) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
  Nov 5, 2025 - $TEVA